Below are a series of videos from MSF on different aspects of HIV/AIDS treatment.
A first-of-its-kind study released today by Doctors Without Borders/Médecins Sans Frontières (MSF) maps progress across 23 countries on HIV treatment strategies, tools and policies needed to increase treatment scale-up. The results show that governments have made improvements to get better antiretroviral treatment (ART) to more people, but implementation of innovative community-based strategies is lagging in some countries.
Despite the fact that the benefits of virological treatment monitoring are well established and that routine viral load testing is the standard of care in rich countries, access to viral load testing in resource-limited settings remains limited or non-existent. A number of cost-reducing strategies and implementation challenges must now be addressed so that virological monitoring can become the norm for all patients on ART. This will be important to prevent the development of drug resistance and preserve the use of first-line ART. This session presents the challenges and promise of scale-up of virological monitoring from a patient, health system, and market perspective. The session will be of interest to donors, policy makers, civil society representatives, and implementing organizations.
As HIV treatment is scaled up in developing countries, the lack of access to viral load monitoring—routine in wealthy countries—must be addressed. Increased access to viral load monitoring can help people stay on antiretroviral combinations as long as possible, and help stave off resistance.